期刊
CHEMICAL COMMUNICATIONS
卷 57, 期 28, 页码 3457-3460出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/d1cc00957e
关键词
-
资金
- EPSRC [EP/P020291/1] Funding Source: UKRI
A novel enzyme cleavable linker for antibody-drug conjugates, utilizing a highly hydrophilic dual-cleavable 3-O-sulfo-beta-galactose linker, shows excellent cytotoxicity and selectivity in targeted cells when used to synthesize an alpha-HER2 antibody-drug conjugate.
A novel enzyme cleavable linker for antibody-drug conjugates is reported. The 3-O-sulfo-beta-galactose linker is cleaved sequentially by two lysosomal enzymes - arylsulfatase A and beta-galactosidase - to release the payload in targeted cells. An alpha-HER2 antibody-drug conjugate synthesised using this highly hydrophilic dual-cleavable linker exhibited excellent cytotoxicity and selectivity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据